LTLip-Yuen Teng

Lip-Yuen Teng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lip-Yuen Teng has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Heung Dong Kim

    Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea

    3 shared publications
  • Ahmad Rithauddin Mohamed

    Paediatric Neurology Unit, Department of Paediatrics, Hospital Tunku Azizah, Kuala Lumpur, Malaysia

    2 shared publications
  • Ara Ko

    Division of Pediatric Neurology, Severance Children’s Hospital, Seoul, Republic of Korea

    1 shared publication
  • Daehyun Kim

    Yonsei University College of Medicine, Seoul, Republic of Korea

    1 shared publication
  • Daewoong Ahn

    Yonsei University College of Medicine, Seoul, Republic of Korea

    1 shared publication
  • Dianah Abd Hadi

    Paediatric Neurology Unit, Department of Paediatrics, Hospital Tunku Azizah, Kuala Lumpur, Malaysia

    1 shared publication

Latest Publications

  • Open Access

    Structural brain MRI abnormalities in SCN1A-, SCN2A-, SCN3A-, and SCN8A-related epilepsies: a cohort study

    by Daewoong Ahn, Daehyun Kim, Hyeon Deok Sang, Heeseung Cho, Ara Ko, Na-Young Shin, Hoon-Chul Kang, Joon Soo Lee, Lip-Yuen Teng, Se Hee Kim

    Purpose: To characterize the prevalence and patterns of structural brain magnetic resonance imaging (MRI) abnormalities in children with genetically confirmed SCN1A -, SCN2A -, SCN3A -, or SCN8A -related epilepsy and to identify genotype-specific imaging features. Methods: We retrospectively analyzed brain MRI findings from a single-center cohort of 139 pediatric patients with pathogenic variants of SCN1A ( n = 114), SCN2A ( n = 17), SCN3A ( n = 1), or SCN8A ( n = 7), evaluated between 2010 and 2023. MRI abnormalities were categorized using a standardized classification framework and compared across the genotypes. Results: MRI abnormalities were identified in 52 of the 139 patients (37.4%). The most common findings were atrophy (21.6%), hippocampal abnormalities (6.5%), white matter signal abnormalities (5.0%) and hypoxic–ischemic encephalopathy (3.6%). Abnormalities were most frequent in the SCN2A (70.6%) group, followed by the SCN8A (42.9%) and SCN1A (31.6%) groups; one patient with SCN3A -related epilepsy also exhibited abnormal findings. In SCN1A -related epilepsies, the most common abnormalities were cerebral atrophy (15.8%) and hippocampal abnormalities (6.1%). In SCN2A -related epilepsies, common abnormalities included atrophy (58.8%), white matter signal abnormalities (17.6%), hypoxic–ischemic encephalopathy (11.8%) and malformations of cortical development (11.8%). In SCN8A -related epilepsies, common findings included atrophy (28.6%), hippocampal abnormalities (14.3%), and white matter signal abnormalities (14.3%). One patient with SCN3A -related epilepsy exhibited vascular abnormalities. Conclusion: Contrary to earlier assumptions, structural MRI abnormalities are common in SCN -related epilepsies, particularly in SCN2A -and SCN8A -related epilepsies. MRI may aid in the diagnosis, phenotypic stratification, and prognostication of genetic epilepsy involving voltage-gated sodium channels.


  • Open Access

    Water Bead Ingestion - An Emerging Unexpected Aetiology of Intestinal Obstruction: A Case Report

    by Teranjeet Kaur Dharamjeet Singh, Lip Yuen Teng

    Foreign body ingestion is common problem in the paediatric population with 80% cases occurring in children under three years old. We reported a case of acute intestinal obstruction secondary to water bead ingestion. A 1-year-9-month-old boy presented with low-grade fever, non-projectile vomiting and severe acute abdomen for a day. The abdomen was distended and tense with generalised tenderness and guarding. There was neither witness of foreign body ingestion nor radio-opaque foreign body seen on the plain abdominal radiography but only presence of dilated small bowels. Ultrasound abdomen revealed grossly dilated fluid-filled small bowel loops with minimal interloop-free fluid. He underwent laparotomy in which a water bead size 4 cm was found 71cm from distal jejunum. Enterotomy with foreign body removal and primary repair was performed. Water beads are made of super absorbent polymer which can grow 100 times their original size when exposed to water. They are often used as home decorative items. Due to their attractive appearance – bright-coloured, crystal ball-like or even resembling candies, they can be easily mistaken by young children as food item and ingested by them. These beads are radiolucent on plain radiographs, frequently leading to delayed diagnosis and treatment. Water bead ingestion is a new and emerging unexpected cause of intestinal obstruction. This may result in choking, internal injuries and even death if left undetected. These objects must be stored out of reach of children. Increasing awareness among the public and medical personnel about home accidents caused by water bead ingestion is essential to prevent similar incidents.

  • Open Access

    mTOR inhibition in epilepsy: A literature review

    by Lip-Yuen Teng, Min Jung Chang, Se Hee Kim

    Hyperactivation of the mammalian target of the rapamycin (mTOR) pathway causes epilepsies, neurodevelopmental disorders, and malformations of cortical development, collectively known as mTORopathies. These conditions arise from loss-of-function variants in negative regulators or gain-of-function variants in positive regulators of the mTOR pathway. Conventional antiseizure medications mainly target downstream effectors such as ion channels or neurotransmitter activity to suppress seizures. On the contrary, extensive pre-clinical and clinical evidence has demonstrated that mTOR inhibitors have anti-epileptogenic or disease-modifying effects, potentially preventing epilepsy or slowing disease progression rather than merely controlling seizures. In general, mTOR inhibitors bind to mTOR protein, preventing its interactions with substrates and disrupting mTOR complex assembly, thereby suppressing downstream activities. In this review, we provide a comprehensive overview of the mTOR signaling pathway, outline the spectrum of mTORopathies and its subset (GATORopathies), and highlight the clinical applications of mTOR inhibitors, particularly everolimus, along with other potential mTOR-modulating agents.


  • Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy

    by Se Hee Kim, Jieun Seo, Soon Sung Kwon, Lip‐Yuen Teng, DongJu Won, Saeam Shin, Joon Soo Lee, Seung‐Tae Lee, Jong Rak Choi, Hoon‐Chul Kang

    Objective: We aimed to identify common genes and recurrent causative variants in a large group of Asian patients with different epilepsy syndromes and subgroups.Methods: Patients with unexplained pediatric‐onset epilepsy were identified from the in‐house Severance Neurodevelopmental Disorders and Epilepsy Database. All patients underwent either exome sequencing or multigene panels from January 2017 to December 2019, at Severance Children's Hospital in Korea. Clinical data were extracted from the medical records.Results: Of the 957 patients studied, 947 (99.0%) were Korean and 570 were male (59.6%). The median age at testing was 4.91 years (interquartile range, 1.53–9.39). The overall diagnostic yield was 32.4% (310/957). Clinical exome sequencing yielded a diagnostic rate of 36.9% (134/363), whereas the epilepsy panel yielded a diagnostic rate of 29.9% (170/569). Diagnostic yield differed across epilepsy syndromes. It was high in Dravet syndrome (87.2%, 41/47) and early infantile developmental epileptic encephalopathy (60.7%, 17/28), but low in West syndrome (21.8%, 34/156) and myoclonic‐atonic epilepsy (4.8%, 1/21). The most frequently implicated genes were SCN1A (n = 49), STXBP1 (n = 15), SCN2A (n = 14), KCNQ2 (n = 13), CDKL5 (n = 11), CHD2 (n = 9), SLC2A1 (n = 9), PCDH19 (n = 8), MECP2 (n = 6), SCN8A (n = 6), and PRRT2 (n = 5). The recurrent genetic abnormalities included 15q11.2 deletion/duplication (n = 9), Xq28 duplication (n = 5), PRRT2 deletion (n = 4), MECP2 duplication (n = 3), SCN1A, c.2556+3A>T (n = 3), and 2q24.3 deletion (n = 3).Significance: Here we present the results of a large‐scale study conducted in East Asia, where we identified several common genes and recurrent variants that varied depending on specific epilepsy syndromes. The overall genetic landscape of the Asian population aligns with findings from other populations of varying ethnicities.


  • Geniospasm: A systematic review on natural history, prognosis, and treatment

    by Lip-Yuen Teng, Dianah Abd Hadi, Poorani Anandakrishnan, Sumitha Murugesu, Teik-Beng Khoo, Ahmad Rithauddin Mohamed


  • Glycemic biomarkers in children with drug‐resistant epilepsy on various types of ketogenic diet therapies: A cross‐sectional study

    by Lip‐Yuen Teng, Vanessa Wan‐Mun Lee, Sumitha Murugesu, Jun‐Xiong Lee, Nur Sakinah Ibrahim, Mohd Fatahudin Ishak, Ahmad Rithauddin Mohamed, Teik‐Beng Khoo

    Objective This study was undertaken to determine the hemoglobin A1c (HbA1c) and modified glucose-ketone index (mGKI) in children on different types of ketogenic diet (KD) for treatment of drug-resistant epilepsy, with attempts to evaluate their relationships with components of diet regime and other biomarkers. Methods We conducted a cross-sectional study in children with drug resistant epilepsy aged between 6 months and 18 years, who were on various types of KD therapies without any change in regime for at least 3 months. Parental interview, review of medical records, and a single measurement for blood ketone, HbA1c, and plasma carnitine were performed. mGKI was the ratio of an average plasma glucose estimated from HbA1c to blood beta-hydroxybutyrate level. Results Thirty-four patients were recruited with a median blood ketone of 2.90 mmol center dot L-1 and median HbA1c of 4.55%. Those on classical KD (cKD) had higher blood ketone (p = .031) and lower HbA1c (p = .010) and mGKI (p = .021) than those receiving modified Atkins diet, although both shared similar percentages of calories from carbohydrate (p = .211). The cKD and medium-chain triglyceride (MCT) KD groups had similar HbA1c (p = .252) and mGKI (p = .510). Blood ketone (p = .045) and the percentage of calories from MCT (p = .037) were the two main independent variables, inversely correlating with HbA1c. Other than plasma acylcarnitine (p = .047), neither blood ketone (p = .188) nor HbA1c (p = .170) could predict seizure reduction reliably. Both plasma acylcarnitine >= 6 mu mol center dot L-1 (p = .013) and mGKI <= 2.2 (p = .013) were significantly associated with good seizure control. Significance HbA1c could potentially be useful for monitoring KD adherence or, indirectly, systemic ketosis in nondiabetic children on KD for drug-resistant epilepsy. Plasma acylcarnitine and mGKI could be important biomarkers in the management of KD therapy.